Brown R H

Johnstone M A, Shingleton B J, Crandall A S, Brown R H, Robin A L

A 2000 survey of US ASCRS members revealed common glaucoma surgery patterns among comprehensive ophthalmologists, offering insight into historical practice styles.

Brown R H, Shingleton B J, Johnstone M, Crandall A, Robin A

A 1999 survey of US ASCRS members revealed common glaucoma laser treatment parameters and practices for trabeculoplasty, iridotomy, and gonioplasty, providing insight into clinical application patterns.

Lynch M G, Roesch M, Brown R H

YAG laser remodeling effectively treated problematic glaucoma filtering blebs (overfiltering, leaking, irritating), improving IOP, sealing leaks, and resolving discomfort, offering a new clinical option.

Gandham S B, Brown R H, Katz L J, Lynch M G

Nd:YAG laser effectively removed pupillary membranes from IOLs, improving vision in most patients by clearing the visual axis, even after steroid failure.

Martinez J A, Brown R H, Lynch M G, Caplan M B

This study found no sudden visual loss after trabeculectomy in 54 advanced glaucoma eyes, suggesting lower-than-reported risk, which is clinically relevant for surgical decision-making.

Ortiz J R, Walker S D, McManus P E, Martinez L A, Brown R H, Jaffe G J

Brown R H, Lynch M G, Denham D B, Parel J M, Palmberg P, Brown D D

An automated trephine for internal sclerectomy safely created filtering fistulas in advanced glaucoma patients, minimizing conjunctival trauma and simplifying antimetabolite use for IOP control.

Brown R H, Stewart R H, Lynch M G, Crandall A S, Mandell A I, Wilensky J T et al.

ALO 2145 safely reduced post-laser surgery IOP spikes, significantly lowering the incidence and magnitude of potentially harmful pressure elevations, offering a protective clinical benefit.

Caplan M B, Brown R H, Love L L

Lynch M G, Peeler J S, Brown R H, Niederkorn J Y

Human trabecular meshwork cells express HLA class I, and inducibly class II antigens, suggesting their role in ocular immune responses and inflammation within the anterior segment.

Jampel H D, Lynch M G, Brown R H, Kuhar M J, De Souza E B

Human trabecular meshwork predominantly contains beta2-adrenergic receptors. This anatomical finding supports beta-blocker outflow effects and guides development of selective beta2 agents to improve glaucoma outflow.

Lynch M G, Brown R H, Michels R G, Pollack I P, Stark W J

Vitrectomy successfully treated pseudophakic malignant glaucoma unresponsive to medical/laser therapies, creating an aqueous pathway without IOL dislocation. This offers a surgical solution for this severe condition.

Davenport W H, Brown R H, Lynch M G

Gilbert C M, Brown R H, Lynch M G

ALT initially reduced glaucoma surgery rates, but they later returned to pre-ALT levels, suggesting ALT delays, but often doesn't prevent, the need for filtering surgery.